Indian Institute of Science Education and Research Pune is a premier autonomous Institution established by the Ministry of Human Resource Development, Government of India, for the promotion of high-quality science education and research in the country.
The Prime Minister's Research Fellowship (PMRF) scheme is aimed at attracting the talent pool of the country to doctoral (Ph.D.) programmes of Indian Institute of Science (IISc), Indian Institutes of Science Education & Research (IISERs), Indian Institutes of Technology (IITs) and Central Universities (which are among the top 100 National Institutional Ranking Framework, NIRF ranked universities) for carrying out research in cutting edge science and technology domains, with focus on national priorities.
The Indo-U.S. Science and Technology Forum (IUSSTF) established under an agreement between the Governments of India and the United States of America in March 2000, is an autonomous bilateral organization jointly funded by both the Governments that promotes Science, Technology, Engineering and Innovation through substantive interaction among government, academia and industry. The Department of Science & Technology, Governments of India and the U.S. Department of States are respective nodal departments.
Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).
Post : Global Product Manager for Global Marketing
Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, set up by Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs. BIRAC is a industry-academia interface and implements its mandate through a wide range of impact initiatives, be it providing access to risk capital through targeted funding, technology transfer, IP management and handholding schemes that help bring innovation excellence to the biotech firms and make them globally competitive. In its Five years of existence, BIRAC has initiated several schemes, networks and platforms that help to bridge the existing gaps in the industry-academia Innovation research and facilitate novel, high quality affordable products development through cutting edge technologies. BIRAC has initiated partnerships with several national and global partners to collaborate and deliver the salient features of its mandate.
The legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.
NISER recognizes that modern scientific research is carried out in interstices amongst fuzzy domains and blurred boundaries. This entails encouraging a new scientific culture where members of our community attain to an intellectual agility unconstrained by the limitations of disciplinary conventions from the past. Faculty and Students will be given generous material support in the pursuit to realize this objective. Time and conversational space will be devoted to nascent propositions and hypothesis and the significantly small student-faculty ratio, an eventual full strength of 2000 students and 300 faculty, manifests the Institutes investment and hope in the future.
CSIR-Central Drug Research Institute, Lucknow, a premier Institute under Council of Scientific and Industrial Research (CSIR), is involved in multidisciplinary R&D programs of both basic and applied nature. CSIR-CDRI is a pioneer biomedical research organization in India and has the infrastructure and expertise to develop a drug from conceptualization to commercialization. In the year 2012, CSIR-CDRI shifted to its state of the art new campus, which has been set up with a vision to serve as a Nodal Center of CSIR in new drug discovery and development.
Regional Centre for Biotechnology (RCB) is an institution of national importance established by the Department of Biotechnology, Govt. of India, under auspices of UNESCO. The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology.
Post : Bioinformatics Expert 2
Quintiles and IMS Health have come together to become IQVIA, The Human Data Science Company. Inspired by the industry we help, IQVIA commits to providing solutions that enable life sciences companies to innovate with confidence, maximize their opportunities and ultimately drive human health outcomes forward.
Post : Pharmacovigilance